Back to results
US 2006/0216345 A1Published application
Oral pharmaceutical composition including paroxetine
AssigneeSun Pharmaceutical Industries Limited
InventorsVaishali Dhavse, Nitin Dharmadhikari
Life of this patent
Estimating the term…
Abstract
A stable oral pharmaceutical composition including a therapeutically effective amount of paroxetine or its pharmaceutically acceptable salt and one or more adjuvants that prevent the formation of pink hue upon storage of the composition. The composition can be prepared by aqueous granulation.
Claims4
A stable oral pharmaceutical composition comprising:
- (i) a therapeutically effective amount of paroxetine or its pharmaceutically acceptable salt, and
- (ii) one or more pharmaceutically acceptable adjuvants selected from the group consisting of lactose anhydrous, lactose monohydrate, pregelatinized starch, sodium starch glycolate, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, polyethylene glycol 6000 and polysorbate 80, silicified microcrystalline cellulose, dicalcium phosphate dihydrate and dicalcium phosphate anhydrous,
- wherein the composition is prepared by aqueous granulation.
A stable oral pharmaceutical composition comprising:
- (i) a therapeutically effective amount of paroxetine or its pharmaceutically acceptable salt, and
- (ii) pharmaceutically acceptable adjuvants comprising lactose, pregelatinized starch, sodium starch glycolate and magnesium stearate,
- wherein the composition is prepared by aqueous granulation.
Dependencies are inferred from the claim text.